Details werden geladen...
Alnylam to partner with Inceptive Nucleics for AI foundation models for RNAi therapeutics
Alnylam announced a three-year deal with Inceptive Nucleics, worth up to $2 billion, with $30 million upfront in cash and equity in the startup.
Ähnliche Seiten
Servier to buy Edgewise Therapeutics' muscular dystrophy drug | STAT
https://www.statnews.com/2026/06/01/servier-edgewise-therapeutics-muscular-dystrophy-drug-sevasemten/
Alnylam, Inceptive Ink AI Drug Development Deal Worth Up To $2 Bln | 04.06.26 | finanzen.at
https://www.finanzen.at/nachrichten/aktien/alnylam-inceptive-ink-ai-drug-development-deal-worth-up-to-$2-bln-1036224113Roche to acquire startup PathAI for $750 million upfront | STAT
https://www.statnews.com/2026/05/08/roche-acquire-startup-pathai-750-million-upfront/
Netflix and Spotify Partner Up for Jay Shetty's 'On Purpose' Podcast
https://www.thewrap.com/industry-news/business/jay-shetty-on-purpose-podcast-netflix-spotify-deal/
Insilico Medicine and Human Longevity Announce Collaboration to Co-Develop Industry-First AI Foundation Model for Longevity Science | The Manila Times
https://www.manilatimes.net/2026/05/26/tmt-newswire/pr-newswire/insilico-medicine-and-human-longevity-announce-collaboration-to-co-develop-industry-first-ai-foundation-model-for-longevity-science/2351874